Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2019.1554053
Abstract: ABSTRACT Introduction: Ankylosing spondylitis is the prototype of spondyloarthritis, a chronic inflammatory disease involving mainly the axial skeleton. The treatment strategy was, until now, restricted to NSAIDs and anti-TNF agents. Targeting Interleukin 17 is an… read more here.
Keywords: ankylosing spondylitis; monoclonal antibodies; treatment ankylosing; anti monoclonal ... See more keywords
Treatment of ankylosing spondylitis with co‐amoxiclav
Sign Up to like & getrecommendations! Published in 2018 at "Clinical and Experimental Pharmacology and Physiology"
DOI: 10.1111/1440-1681.12952
Abstract: This article presents the efficacy of co‐amoxiclav in two patients with ankylosing spondylitis. Both patients were administered oral co‐amoxiclav for 7 days. The primary efficacy variable was the ankylosing spondylitis activity index. Secondary outcome measures… read more here.
Keywords: spondylitis amoxiclav; ankylosing spondylitis; treatment ankylosing; pharmacology ... See more keywords